securities act release no. 5310

  1. K

    Dr. Reddy's Laboratories: SEC Closes Probe Into Alleged Improper Payments, No Enforcement Action Recommended

    SEC Concludes Investigation Under FCPA Review Dr. Reddy's Laboratories Ltd has received a formal communication from the US Securities and Exchange Commission stating that it has concluded its investigation into allegations of improper payments and does not intend to recommend any enforcement...
Back
Top